+Make Appointment

About Us

Recent Thesis Topic (2016-18)

Recent Thesis Topic (2016-18) Role
Effect of weightloss (achieved by Bariatric surgery) on various cardiovascular risk factors (glycemic control, hypertension, lipid profile, CRP & homocysteine) Guide
Relationship of severity of CAD with anti proBNP in acute coronary syndrome Guide
Aspirin & clopidogrel resistance in Indian patients with coronary artery disease & their associations with CYP2CI9 Guide
Anaemia profile in patients with congestive heart failure Guide
The study of prevalence of Familial hypercholesterolemia in patients with premature coronary artery disease Guide
A study of genetic mutations in familial dilated cardiomyopathy. Guide
Study of urinary NGAL as early predictor marker of contrast induced nephropathy in diabetic patients undergoing coronary angioplasty. Guide

Recent thesis Coguide for MSc, DNB, PhD students (2016-18) :

  • Effect Of 4 Weeks Of Exercise Training On Cardiac Remodelling And Different Quality Of Life Parameters In CAD Patients.
  • Comparison of the two dimensional versus three dimensional transthoracic echocardiography in assessment of mitral regurgitation.
  • Effect of yoga lifestyle on ambulatory blood pressure in patients with high-normal blood pressure (prehypertension) A randomized pilot study.
  • Molecular characterization of familial Hypercholesterolemia in Indian Population.
  • Comparison of the two dimensional versus three dimensional versus three dimensional transthoracic echocardiography in assessment of mitral regurgitation.

Recent CME conducted (2016-2018):

  • Management of hypertension – recent advances
  • Management of heart failure
  • Management of Dyslipidemia
  • Management of Acute coronary syndrome
  • Lessons learned from ACC/ESC conferences

Pioneering work

  • Bringing global clinical trial to private sector Hospital
  • Establishing preventive and cardiac Rehabilitation programme
  • Prevention of cardiovascular disease in Young Indian community- Familial Hypercholesterolemia diagnosis and management
  • Promotion of group practice to improve patient care & helped to develop medical sub-specialties .

Bringing global clinical trial to private sector Hospital:

Dr. Sawhney has Excellence in research. He pioneered the research in private sector. Not only in Sir Ganga Ram hospital but also he initiated the research program in other private hospitals of Delhi and around. He has conducted many National & International clinical trials of global importance (Phase – II, III & IV) as Principal investigator:

  • SGRH. Dept of Cardiology is considered to be one of the best centre for Clinical research & trial in North India.
  • Received Achievement award for Extract TIMI trial from Dr. Braunwald.
  • Member of Steering Committee for clinical trials.
  • National Coordinator for global Registry of Hypertension, Heart failure, Acute coronary syndrome, Atrial fibrillation and Lipids (EPICOR, GARFIELD,DYSIS,ASIAN-HF etc.)
  • National Coordinator for global clinical trials

Establishing preventive and cardiac Rehabilitation programme:

In March’2010, under the chairmanship of Dr. JPS Sawhney, Dharma Vira Heart Center started department of cardiovascular prevention and rehabilitation which is the first cardiac rehabilitation set up in North India and second in India. This new cardiac rehabilitation facility was created after the joining of Dr.Kushal Madan. This new Department of cardiovascular prevention and rehabilitation is providing in patient as well as out patient comprehensive cardiac rehabilitation to cardiac as well as cardiac surgery patients. We are successfully providing outpatient cardiac rehabilitation including exercise prescription and training, psychological counseling, diet counseling and yoga training.

Prevention of cardiovascular disease in Young Indian community-Familial Hypercholesterolemia

Most original and recognizable contribution of Dr. Sawhney towards the society is related to his pioneering research associated with prevention of heart attacks in Young Indian community.

  • Name: Prevention of cardiovascular disease in Young Indian community
  • Location: Department of Cardiology and Department of Medical Genetics, Sir Ganga Ram hospital, New Delhi, India

Key objective: To diagnose familial Hypercholesterolemia (FH) in patients of young myocardial infarction by using Dutch Lipid Network clinic criteria and genetic testing.
Cascade screening of the family members to identify potential carrier of FH gene.

By identification we will be able to identify the patients who are prone for cardiovascular disease and thereby prevent heart attacks by preventive strategies.

Target set: male patients with early heart attack (age above 55 years) and female patients with early heart attack (above 65 years) with high Low Density Lipoprotein cholesterol and history of premature cardiovascular disease in the family.

Target achieved: 707 patients

Impact Made: It is an ongoing study and it has a unique potential to prevent heart attacks in young Indians. FH is a potentially lethal yet highly treatable condition which remains under diagnosed and undertreated in most parts of the world. Due to India’s remarkable population size, it is home to a significant number of FH patients. There is therefore a tremendous need for further research to be done, to determine the true prevalence of FH in India. The Dutch Lipid Clinic Network criteria is a simple way to diagnose FH clinically. One should suspect FH in patient of premature CAD & LDL>190mg. The cascade screening applied to nationwide programs will most certainly have an immense impact on reducing the health care burden by diagnosing and treating FH in India. To evaluate how FH contributes to the CVD epidemic in India, knowledge of FH must be disseminated to health care providers and families at all levels and in various specialties, via seminars, conferences, and journals.

“By diagnosing a case of FH, we do not identify a case but a family at risk”

Conferences participated:

  • Attended every year ACC (American College of Cardiology) at USA – since 1997
  • Attended every year ESC (European Society of Cardiology) meeting in Europe — since 1998
  • Attended every year CSI (Cardiology Society of India) in India — since 1989.
  • Attended International Conference in preventive Cardiology at Brazil—in 2005.
  • Attending every year Annual Conference of European Society of Heart Failure.
  • Attended Europrevent Conference every year as faculty ( Prague, Spain, Slovenia, Switzerland)
  • Attending Annual Symposia organized by Pharma industry as speaker & course director.

Preventive Cardiology:

  • Organized “Healthy Heart” Symposia in 1999.
  • Refresher Course in Preventive Cardiology for family physicians in 2000.
  • Public Lectures/ awareness programme in association with camps in many part of Delhi & North India
  • Heart Protection Society — Member and Chairperson.

Objectives

  • Prevention of Cardio Vascular Disease.
  • Education to fellow physician.

Conferences organized:

  • 1. Four International conference in cardiology between 1995-2001 at Delhi
  • 2. Ten National conferences in Delhi under IMA/DMA banner.
  • 3. Organized three refresher course in cardiology - at Sir Ganga Ram Hospital
  • 4. Organized ECG workshop — in 2002
  • 5. Organized Cardiology update & Symposia with IMA-CGP since 1999 every year.
  • 6. Organizing secretary for continuous Medical Education Programme of Department of Cardiology SGRH – every 2 months for last 6years.
  • 7. Heart protection programme—a teaching CME for fellow physician every month for 1 year.

Social activities:

  • Member Rotary International –Southend Branch, Delhi –Paul Harris Fellow
  • Organised “Cardiac Check Up” camp under the banner of Rotary Club.
  • Member World Punjabi Organization.
  • Cardiac check up camps in Delhi and neighboring states.
  • Delivered Public Lectures –on “Preventive Cardiology” in collaboration with various social organizations.
  • Captain Cricket Club of SGRH

Lectures and Orations:

Invited as faculty to national and Internationsl conferences.

Presented more than 400 lectures in National and International Conferences of Cardiology.

CSI Annual meeting Lectures after 2010

Year Title Plcae
Dec’ 2017 Familial Hypercholesterolemia Kolkata
Dec’ 2016 Role of PCSK9 inhibitors in Familial Hypercholesterolemia Cochin
Dec’ 2015 Recent advances in the management of Chronic Heart Failure Hyderabad
Dec’ 2014 New calcium channel blockers for the management of Hypertension Mumbai
Dec’ 2013 NOACs vs. Vit. K Antagonists Bangaluru
Dec’ 2012 Stroke Prevention in Atrial Fibrillation (SPAF) New Delhi
Dec’ 2011 Lessons learned from recent clinical trials New Delhi
Dec’ 2010 Prevention of Hypertension Cochin

Delhi Medical association Lectures

Year Title Plcae
2013 Comprehensive management of dyslipidemia in clinical practice New Delhi
2014 Comprehensive management of dyslipidemia in clinical practice New Delhi

Research Society for the Study of Diabetes in India (RSSDI) Lectures

Year Title Plcae
2016 Management of heart Failure in DM with reference to SGLT2 New Delhi
2015 Management Of Diabetes Mellitus Current Understanding Of CV Safety – Evidence With Dpp4i New Delhi
2013 Gliptin in Cardiovascular Disease Greater Noida

International Lectures

Year Title Plcae
2017 Risk profiles and outcomes of patients with newly diagnosed atrial fibrillation – Results from India London
2017 APHRS 2017 – Satellite Symposium Clinical and economic burden of AF in Asia:Real-life data from the GARFIELD-AF registry Yokohama, Japan
2016 APHRS 2017 – Satellite Symposium Clinical and economic burden of AF in Asia:Real-life data from the GARFIELD-AF registry Dubai
2016 APHRS 2017 – Satellite Symposium Clinical and economic burden of AF in Asia:Real-life data from the GARFIELD-AF registry Moscow
2015 APHRS 2017 – Satellite Symposium Clinical and economic burden of AF in Asia:Real-life data from the GARFIELD-AF registry Vancouver
2015 Optimal management of Hypertension with co-existent Respiratory disease. Krabi Island
2014 Management of Hypertension – 2014 Role of ARBs Mauritius
2018 GARFIELD registry London

Indian Medical association lectures every year since 1995- till now on different topics of cardiology like Hypertension, Atrial Fibrillation, Congestive Heart Failure, Acute coronary syndrome, lipid disorders and preventive cardiology etc.

Research

He has conducted many National & International clinical trials (Phase – II, III & IV) as Principal investigator:

  • SGRH. Dept of Cardiology is considered to be one of the best centres for Clinical research & trial in North India.
  • Received Achievement award for Extract TIMI trial from Dr. Braunwald.
  • Epidemiological study done to look at incidence of Metabolic Syndrome in Indian Urban population.
  • Study to look at usefulness of Framingham risk score in Indian population.

Completed Global Clinical Trials as Principal Investigator

  • Extract Timi 25 - Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction Study 25
  • A Safety and Efficacy Dose – Ranging Study of GAP -486 in subjects with Non Sustained Ventricular Tachycardia and Acute Ischemia.
  • Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels (GEMINI-AALA)
  • A Phase III, Open Label, Multicentric, Parallel Group, Randomized Study to Evaluate the Safety and Efficacy of Abciximab in Indian Patients Scheduled for Percutaneous Coronary Intervention.
  • A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE).
  • SEPIA / ACS A Randomized, double –blind, triple dummy, dose ranging study including an active control of unfractionated heparin and eptifibatide, to evaluate the clinical efficacy and safety of otamixaban, in patients with non- ST elevation acute coronary syndrome and planned early invasive strategy.
  • A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Lipid-Altering Efficacy, Safety and Tolerability of MK-0524A in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia
  • CURRENT/ACS - A Randomized, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or myocardial infarction managed with an early invasive strategy (Study No. EFC5965).
  • PLATO/ACSA Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A Study of PLATelet inhibition and Patient Outcomes.] Study Code: D5130C05262
  • ASCEND HF/ CHF Protocol A 093;Double Blind, Placebo Controlled, Multicentre, and Acute Study of clinical effectiveness of Nestritide in subjects with Decompensated Heart Failure.
  • BOREALIS /AF A multi-centre, randomized, double –blind, non-inferiority study comparing the Efficacy and safety of once –weekly subcutaneous biotinylated idraparinux with oral adjusted –dose warfarin in the prevention of stroke and systemic thromboemlic events in patients with atrial fibrillation.
  • CONVERT H/CHF 087-CL-301, Phase 3b, Randomized, Double blind, Placebo Controlled, Multi-center Study to Assses the safety and Efficacy of Conivaptan in Symptomatic Acute Decompensated Heart Failure (ADHF) subjects with Hyponatremia.
  • APPRAISE Title: A clinical research study of APixaban for Prevention of Acute Ischemic Events-2.
  • RELY-- Comparing the efficacy and safety of two blinded dose of debigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patinets with non valvular atrial fibrillation prospective, multicentre parallel group, non inferiority trial.
  • FUTURA / ACSAR110888 – Fondaparinux Trial with UFH during Revascularisation in acute Coronary Syndromes (FUTURA): A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with UA/NSTEMI initially treated with subcutaneous fondaparinux and referred for early Coronary angiography (OASIS 8)
  • POLYCAP A randomized double-blind controlled trail of the efficacy and safety of the POLYCAP versus its components in subject with at least one additional cardio-Vascular risk factor.
  • ATLAS ACS-2 TIMI 51Title: The second trial of Anti Xa Therapy to Lower Cardiovascular events in Addition to Standard therapy in subjects with Acute Coronary Syndrome
  • IRISH / Stable Angina Evaluation of anti-anginal efficacy & safety of oral administration of Ivabridine compared to Placebo on top of a Backward Therapy with a Calcium Antagonist (Amlodipine or Nifedipine) in Patients with stable angina pectoris. A 6-week randomized double Blind Parallel Group international multicentric study.
  • Freedom (302)Title: A 12 week, International, multicenter, double blind, randomized, placebo-controlled comparison of the Efficacy and Safety of oral UT-15c sustained Release Tablets in Subjects with Pulmonary Hypertension.Drug: UT- 15c (The prostinil Diethanolamine)
  • RELY-ABLE: 1160.71 - Long Term Multi-center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation Who Completed the RELY Trial and a Cluster Randomized Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes.”
  • CLCZ696B2214: A 36 week, Randomized , Double-blind, Multi-center,parallel group, active controlled study to evaluate the efficacy, safety & tolerability of LCZ696 compared to valsartan in patients wiyh chronic heart failure & preserved left-ventricular ejection fraction.
  • ENGAGE-AF Title: Phase-3, Randomized, Double blind, Double dummy parallel group, Multicenter, Multinational Study for Evaluation & Efficacy and Safety of DU176b versus Warfarin in Subjects with Atrial Fibrillation- Effective Anticoagulation with factor XA Next Generation in Atrial Fibrillation (ENGAGE-AF-TIMI-48)Indication: Atrial Fibrillation Study Molecule: Edoxaban (X inhibitor warfarin).
  • TAO: To Randomized, double-blind , triple-dummy trialto compare the efficacy of otamixaban with Unfractionated Heparin + eptifibatide, In patients with Unstable angina/Non ST segment Elevation Myocardial Infaraction scheduled to undergo an antigina/Non ST SEGMENT elevation Myocardial Infaraction scheduled to undergo an early Invasive Strategy.
  • Cleopatra - Efficacy of the Long-Acting Nitro Vasodilator Pentaerithyrityl Tetranitrate in Patients With Chronic Stable Angina Pectoris Receiving Anti-Anginal Background Therapy With Beta-Blockers: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
  • Protocol 108 -00 A 16 week, Randomized, Placebo Controlled study to valuate the Efficacy and safety of Extended release Niacin/Laropiprantin south and Southeast Asians not on a Lipid Modulating Agent with Decreased High Density Lipoprotein Cholesterol and Low –Density Lipoprotein Cholesterol at or Below NCEP ATP III Goal.
  • STABILITY / ACS LPL 100601 A clinical Outcome Study of Daraplabib versus Placebo in Subjects with Chronic Coronary Disease to compare the incidence of major Cardiovascular Events.
  • ATMOSPHERE / CHF Title: A multicenter, randomized, double blind, parallel group, active-controlled study to evaluate the Efficacy and Safety of both ALISKIREN monotherapy and aliskiren/enalapril combination therapy compared to enalapril monotherapy on morbidity & mortality in patients with chronic Heart Failure (NYHA class II to IV).
  • SOLID- TIMI (SB480848/033) Protocol Title (Study Name): A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).(Short title: The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 [SOLID-TIMI 52] Trial)
  • Protocol EFC11570 (ODYSSEY CV): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
  • Protocol Title : A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Event Driven Study to Compare the Time to First Clinical Worsening in Subjects with Pulmonary Arterial Hypertension Receiving UT-15C in Combination with a PDE5-I or ERA Compared with a PDE5-I or ERA Alone
  • Profiling of Implantable Cardiac Device Diagnostics trends during Clinical Event for co-morbid conditions in Indian Patients (PATTERNS).
  • CV185316 - “An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention."
  • SPREAD study (Secondary Prevention of coRonary Events After Discharge from hospital).
  • Pilot project “Employee Health Risk Assessment” i.e. evaluate the risk of future diseases and the present health of individuals working at Sir Ganga Ram Hospital.

Ongoing Clinical Trials as Principal Investigator

  • Study Title: A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus[THEMIS - effect of Ticagrelor on Health outcomes in diabEtes Mellitus patients Intervention Study].
  • Amplitude-O: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk.
  • SERDIA: Efficacy and tolerability of Fixed Dose Combination of perindopril+ indapamide +amlodipine in patients with grade II/III hypertension.
  • SELECT: Semaglutide effects on cardiovascular outcomes in people with overweight or obesity.
  • REPATHA: A multicenter, Open label, Single arm, study to evaluate the safety and tolerability of Repatha in patients with Homozygous Familial Hypercholesterolemia (HoFH) in India

Registry

  • RE-LY AF Registry: Risk Factors, Treatments and Outcomes for Emergency Department Patients with Atrial Fibrillation in Multiple Regions of the World.
  • Clarify Registry – Prospective, Observational Longitudinal Registry of patients with stable coronary artery disease.
  • Smart Registry –
  • Remains - Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
  • Global Anticoagulant Registry In the Field (GARFIELD) – Prospective, multi centre, international registry of male and female patients newly diagnosed with atrial fibrillation.
  • A prospective observational study to examine the risk factor of premature Coronary Artery Disease (CAD) in Indians.
  • CAD PAD – A registry of high risk patients with Coronary or peripheral artery disease.
  • Asian Sudden Cardiac Death In Heart Failure (ASIAN-HF) Prospective Observational Registry.
  • Dyslipidemia International Study II (DYSIS II) –Lipid target achievement in high risk patients with Coronary Heart Disease (DYSIS II ACS/CHD).
  • International ambulatory blood pressure registry: Telemonitoring of hypertension and cardiovascular risk project. Artemis registry.

Completed Global Clinical Trials as Co-Investigator

  • Protocol: TMC-CAN-05 02, “A clinical trial comparing Cangrelor to Clopidogrel in subjects who require percutaneous coronary intervention.
  • TMC CAN – 05 03 / ACS “A clinical trial comparing treatment with Cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention”.
  • CRISP MI / ACS A multicenter, randomized controlled study of mechanical left ventricular Unloading with counterpulsation to reduce infarct size Pre PCI for acute MI.
  • The BALANCE Study (Treatment of HyponatrEmia BAsed on LixivAptan in NYHA class III-IV Cardiac Patient Evaluation).
  • CANVAS Protocol 28431754DIA3008: A Randomized, Double-Blind, Parallel, Placebo-Controlled, Multicenter Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus. The CANVAS Trial (CANagliflozin CardioVascular Assessment Study)
  • Ruby A Randomized, Double Blind, Placebo Controlled Multicenter and Parallel Group Study of the Safety, Tolerability and Efficacy of YM150 in combination with Standard Treatment in Secondary Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes (RUBY1)
  • H7T-CR-TAEH Title: A Comparison of Platelet inhibition following a Prasugrel 60mg or Prasugrel 30mg Loading Dose in Acute Coronary Syndrome Subjects Who are to undergo Percutaneous Coronary Intervention
  • ARISTOTLE /AF A phase iii, active (warfarin) controlled, Randomized, double-blind, parallel arm study to evaluate Efficacy and safety of apixaban in preventing stroke and Systemic embolism in subjects with nonvalvular atrial fibrillation (aristotle: apixaban for reduction in stroke and other thromboembolic Events in atrial fibrillation
  • PARADIGM / CHFA multicenter, randomized, double blind, parallel group, active-controlled study to evaluate the Efficacy and Safety of both LCZ 696 compared to enalapril monotherapy on morbidity & mortality in patients with chronic Heart Failure and reduced ejection fraction.
  • ALCARDEO /ACS with DM II Cardiovascular outcomes study to evaluate the Potential of Aleglitazar to reduce cardiovascular risk in Patients with a recent acute coronary syndrome (ACS ) event & type 2 Diabetes Mellitus (T2D ).
  • InSight – Clinical Evaluation of ST Changes in a Group of Patient shaving Ventricular Arrhythmias.
  • A prospective, multicentre, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India. CIP No: NANO/INN/SUP/001
  • TUXEDO – India, A prospective, single blind, Multi-center, Randomized trial to compare the TAXUS element coronary stent system against the XIENCE prime coronary stent system in the treatment of a diabetic population in India.
  • AMR -0101-0019, A Multicenter, Prospective, Randomized, Double blind, Placebo Controlled, Parallel Group study to Evaluate the Effect of AMR101 on cardiovascular Health and Mortality in Hypertriglycerdemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease : REDUCE –IT.
  • FREEDOM 304 / PAH 304(open label study)Title: An open label extension trial of UT-15c SR in subjects with pulmonary Arterial Hypertension.
  • Protocol Title: “An Open-Label Extension Study of UT-15C in subjects with Pulmonary Arterial Hypertension – A Long-Term Follow-Up to Protocol TDE-PH-310.” Protocol no. TDE-PH-311
  • Protocol Title: International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF).

Ongoing Clinical Trials As Co Investigator

  • CANTOS – A randomized, Double blind, placebo controlled, event driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post – myocardial infarction patients with elevated hsCRP.
  • A multicentre, randomized, double-blind, parallel group, active control study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction.
  • A 24-week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction.
  • A multicentre, randomized, double blind, parallel group active controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan on morbidity and mortality in Heart failure patients (NYHA Class II – IV) with preserved ejection fraction.
  • A Phase III randomised, Double-Blind Trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart failure with reduced Ejection Fraction (HRrEF)
  • A Phase III randomized, double-blind trial to evaluate efficacy and safety safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF)
  • Prospective, Single arm, Multi-centre, Observational registry to further validate safety and efficacy of the Ultimaster DES System in Unselected Patients representing everyday clinical practice

Bibliography:

Chapters in Books:

  • SS Iyengar, JPS Sawhney. Guidelines: What to Adopt ? In: SS Iyenger, RR Kasliwal editors. Practical guide to Managing Hypertension. Elsevier; 2010. Page 1-10.
  • JPS Sawhney. Management of Dyslipidemia in Difficult Clinical Situations. In: Jamshed J.Dalal, H.M.Mardikar editors. CAD Update 2013. Cardio Vascular Society of India. Elsevier; 2013. Page.85-96.
  • Kushal Madan, JPS Sawhney. Cardiac Rehabilitation the forgotten Therapeutic option. In: K Venugopal editor. Cardiological Society of India Update Book 2013. Page 199-207.
  • JPS Sawhney. History of ACE-Inhibitors. In: HK Chopra, Navin C Nanda editors. Textbook of Cardiology A clinical & historical perspective. Jaypee; 2013. Page 73-75.
  • Kushal Madan, JPS Sawhney. “Post MI: Risk Stratification and Cardiac Rehabilitation.” In: H K Chopra editor. Cardiological Society of India Update Book 2014.
  • JPS Sawhney, Dileep K Tiwari, Simran Sawhney. Statins and new guidelines – Are they relevant to Indian population ? In: Jamshed J.Dalal, N Deshpande, H.M.Mardikar editors. CAD Update 2014. Cardio Vascular Society of India. Elsevier; 2014. Page.59-69.
  • JPS Sawhney. “Cardiac Rehabilitation after STEMI”. In: H K Chopra editor. STEMI Update 2015.Page 1242-1247.
  • JPS Sawhney, Tanushree Pal. “Telmisartan: relevance of choice of formulation in the setting of STEMI”. In: H K Chopra editor. STEMI Update 2015. Page 541-548.
  • JPS Sawhney, Saurabh Bagga, Simran Sawhney. “Newer modalities of LDL lowering”. Cardiological Society of India Update Book 2015. Page 24-30.
  • JPS Sawhney, Saurabh Bagga,Kushal Madan. “Cardiac rehabilitation in Coronary Artery Diseae”. In: Shirish Hiremath editor. Cardiological Society of India Update Book 2016. Jaypee Brothers Medical Publishers (P) Ltd. Pages: 135-140.
  • J P S Sawhney, Kaushal Gandhi, Saurabh Bagga, Simran Sawhney. “AF management strategies in medically managed ACS”. In : HK Chopra, GS Wander, Praveen Chandra, Viveka Kumar editors. Atrial Fibrillation Update A Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2016. Pages:403-406.
  • JPS Sawhney, Simran Sawhney, Saurabh Bagga. Hypertension and coronary artery disease. In: BA Murugunathan (eds.). Manual of Hypertension, Hypertension society of India. Jaypee Brothers Medical Publishers (P) Ltd. 2016. Pages: 336-342.
  • JPS Sawhney. “What is heart attack?” In: JPS Sawhney, Rajiv Passey, Atul Kakar, Samiran Nundy. Heart Attack. Elsevier. 2016. Pages: 1-7.
  • JPS Sawhney, Simran Sawhney, Saurabh Bagga. Familial Hypercholesterolemia in Routine Cardiac Practice: Recognition and Management. In Sarat Chandra K, Bansal M (Eds). Cardiology Update 2017. Cardiological Society of India, Elsevier (RELX India Pvt Ltd), Gurgaon, India 2017. Pages: 109- 114. (ISBN: 978-81-312-5285-7).
  • JPS Sawhney, Kushal Madan, Simran Sawhney. Post STEMI Intervention rehabilitation in cardio diabetes. In : HK Chopra, SR joshi, GS Wander, RR Kasliwal, Viveka Kumar, AK Pancholia editors. Cardio Diabetes Update : Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2017. Pages: 847-852.
  • JPS Sawhney, Arjun Sreekumar, Saurabh Bagga. Clinical spectrum of Cardiodiabetes: How Indians are different ? In : HK Chopra, SR joshi, GS Wander, RR Kasliwal, Viveka Kumar, AK Pancholia editors. Cardio Diabetes Update : Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2017. Pages: 3-6.
  • JPS Sawhney, Saurabh Bagga, Simran Sawhney. Hyperlipidemias: Focus on Familial hypertryglyceridemia and Familial hypercholesterolemia. In SN Narasingan (Eds.). Monograph Lipidology in Clinical Practice. Jaypee Brothers Medical Publishers (P) Ltd.2017. Pages: 224-232.
  • JPS Sawhney, Kushal Madan. Alcohol & CAD: Fact vs. Fiction. In KC Goswami (Eds). Cardiology Update 2018. Cardiological Society of India, 2018.
  • JPS Sawhney, Kushal Madan,Simran Sawhney, Shashi Ranjan. “Familial hypercholesterolemia”. In KK Pareek (Eds). Medicine Update 2019. Jaypee Brothers Medical Publishers (P) Ltd.
  • JPS Sawhney, Kushal Madan, Simran Sawhney. Cardiac Rehabilitation after Myocardial Infarction. In: Jamshed J.Dalal, (Eds.). CAD Update 2018. Cardio Vascular Society of India. Pages 87-94
  • JPS Sawhney, Prashant Wankhade , Simran Sawhney. Lipid Evaluation: Diagnostic, Prognostic & Clinical Therapeutic Implications. In : Advances in Clinical Cardiovascular Imaging, Echocardiography & Interventions: Textbook of Cardiology. H.K. Chopra, Navin C. Nanda, Jagat Narula (Eds.). Jaypee Brothers Medical Publishers (P) Ltd.2018. Pages: 1155-1161.
  • JPS Sawhney. The growing presence of India in global studies. In: CSI textbook of Cardiology The Indian Perspective. Prdip K Deb (Eds.). Jaypee Brothers Medical Publishers (P) Ltd.2018. Pages: 991-1001.
  • Vyom Mori, Simran Sawhney, JPS Sawhney. “Triglycerides and cardiovascular risk : Have we reached a consensus ?”. In: PP Mohanan, MN Krishnan (Eds.). Cardiology update 2020. Cardiological Society of India. Evangel publishing.2020. Pages 74-77.
  • JPS Sawhney, Kushal Madan, Simran Sawhney. Air Pollution and Hypertension. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, GS Wander, CN Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages: 95-98.
  • JPS Sawhney, Viraj Suvarna, HK Chopra. Power and Promise of Home BP Monitoring. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, GS Wander, CN Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages: 262-266.
  • Kushal Madan, Saurabh Bagga, JPS Sawhney. Exercise Training in Resistant Hypertension. In : H.K. Chopra, Navin C. Nanda, Jagat Narula, GS Wander, CN Manjunath, Praveen Chandra(Eds). Hypertension New Frontiers. Textbook of Cardiology. Jaypee Brothers Medical Publishers (P) Ltd. 2021. Pages:936-938.

Indexed Journal Publications

  • Bassand JP, Apenteng PN, Atar D, Camm AJ, Cools F, Corbalan R, Fitzmaurice DA, Fox KA, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey JL, Sawhney JP, Oh S, Stępińska J, Cate VT, Verheugt FW, Kayani G, Pieper KS, Kakkar AK, Garfield-Af Investigators FT. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke.Future Cardiol. 2021 Jan;17(1):19-38.
  • Setia N, Movva S, Balakrishnan P, Biji IK, Sawhney JPS, Puri R, Arora A, Puri RD, Saxena R, Mishra S, Apte S, Kulshrestha S, Ramprasad VL, Verma IC. Genetic analysis of familial hypercholesterolemia in Asian Indians: Asingle-center study. J Clin Lipidol. 2020 Jan-Feb;14(1):35-45.
  • Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso-Garcia Á, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia study. Int J Cardiol. 2020 Sep 15;315:1-8.
  • Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso Garcia A, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol. 2020 Sep;43(9):999-1008.
  • Ouwerkerk W, Teng TK, Tromp J, Tay WT, Cleland JG, van Veldhuisen DJ, Dickstein K, Ng LL, Lang CC, Anker SD, Zannad F, Hung CL, Sawhney JPS, Naik A, Shimizu W, Hagiwara N, Wander GS, Anand I, Richards AM, Voors AA, Lam CSP. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries. Eur J Heart Fail. 2020 Aug;22(8):1472-1482.
  • Zhang S, Wang W, Sawhney JPS, Krittayaphong R, Kim HS, Nhan VT, Lee SW, Ong TK, Chin CT, Pocock SJ, Huo Y, Qian J, Ge J. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. Int J Cardiol. 2020 Jul 1;310:16-22.
  • Thacker H, Konda Reddy KM, Murthy LS, Sawhney JP, Chaudhary G, Shah S, Joseph S, Rajarshi M, Nikam P. Blood-pressure Lowering Efficacy and Safety of Perindopril / Indapamide / Amlodipine Single-pill Combination in Hypertensive Patients: Phase III Trial in India. J Assoc Physicians India. 2020 Oct;68(10):39-43.
  • Dalal J, Sethi KK, Guha S, Ray S, Deb PK, Kirpalani A, Rao Maddury S, Sathyamurthy I, Shah S, Das MK, Chandalia HB, Sawhney J, Thomas J, Kumar V, Chandra N, Khan A, Kumar AS, Suryaprakash G.Screening for Hypertension in Asymptomatic Individuals in India: An Expert Consensus Statement. J Assoc Physicians India. 2020 Apr;68(4):73-79.
  • Sawhney JPS, Dalal J, A M, Bansal S, Kahali D, Therapeutic Experience of Ticagrelor in Indian Patients with Acute Coronary Syndrome: a Non-Interventional, Prospective, Observational Study, Indian Heart Journal,2019, https://doi.org/10.1016/j.ihj.2019.08.001.
  • JPS Sawhney, Shashi Ranjan Prasad, Manish Sharma, Kushal Madan, A Mohanty , Rajiv Passey , Ashwani Mehta, B Kandpal , Aman Makhija , Rajneesh Jain , RR Mantri , Bhola Shankar Vivek, SC Manchanda , IC Verma. Prevalence of Familial Hypercholesterolemia in premature Coronary Artery Disease patients admitted to a tertiary care hospital in North India. Indian Heart J. 2019 Mar - Apr;71(2):118-122.
  • Goto S, Angchaisuksiri P, Bassand JP, Camm AJ, Dominguez H, Illingworth L, Gibbs H, Goldhaber SZ, Goto S, Jing ZC, Haas S, Kayani G, Koretsune Y, Lim TW, Oh S, Sawhney JPS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK GARFIELD‐AF Investigators. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. J Am Heart Assoc. 2019 Feb 5;8(3):e010510.
  • Apaar Dadlani, Kushal Madan, JPS Sawhney. Ambulatory blood pressure monitoring in clinical practice. Indian Heart Journal. 2019 ;71(1):91-97.
  • Deepak Agrawal, , S.C. Manchanda, J.P.S. Sawhney, , Bhuwanesh Kandpal, Rajneesh Jain, Ashwani Mehta, , Arun Mohanty, Rajiv Passey, Aman Makhija, Manish Kr. Sharma. To study the effect of high dose Atorvastatin 40mg versus 80mg in patients with dyslipidemia. Indian Heart Journal, 2018-12-01, Volume 70, Pages S8-S12.
  • Rishabh Khurana, Anurag Yadav, T.B.S. Buxi, J.P.S. Sawhney, Kishan Singh Rawat, Samarjit S. Ghuman. Correlation of epicardial fat quantification with severity of coronary artery disease: A study in Indian population Indian Heart Journal, 2018-12-01, Volume 70, Pages S140-S145
  • Chanchal Chandramouli, Wan Ting Tay, ; Nurul Sahiddah Bamadhaj, Jasper Tromp, Tiew-Hwa Katherine Teng, Jonathan JL Yap, Michael R MacDonald,Chung-Leih Hung, Koen Streng, Ajay Naik, Gurpreet Singh Wander, Jitendra Sawhney, Lieng Hsi Ling, A.Mark Richards, Inder Anand, Adriaan A. Voors, Carolyn SP Lam. on behalf of ASIAN-HF Investigators.Association of obesity with heart failure outcomes in Asia: a cohort study. 2019. PLOS Medicine
  • Arya V, Mahajan P, Saraf A, Mohanty A, Sawhney JP, Bhargava M. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease. Int J Lab Hematol. 2015 Aug 12. doi: 10.1111/ijlh.12416.
  • Pahlajani D, Kaul U, Mishra A, Mullasari A, Sawhney J, Dargad R, Mehta K, Brar S, Radhakrishnan R, McMahon D, Ibrahim S, Sachanandani H, Sinha N.Medical Management and Diagnostic Testing among Stable Angina Patients in India: The STable Angina obseRvational (STAR) Registry. J Assoc Physicians India. 2015;63(9):20-6.
  • Huo Y, Lee SW, Sawhney JP, Kim HS, Krittayaphong R, Nhan VT, Alonso-Garcia A, Han YL, Ge J, Chin CT, Ong TK, Jan S, Itoh Y, Vega AM, Pocock S. Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia). Clin Cardiol. 2015 Jul 24. doi: 10.1002/clc.22431
  • Sathyamurthy I, Dalal JJ, Sawhney JP, Mohan JC, Chogle SA, Desai N, Sathe SP, Maisel AS. Cardiac Biomarkers for Better Management of Acute Coronary Syndromes. J Assoc Physicians India. 2015 Jun; 63(6):46-50.
  • Sharma M, Sawhney JP, Panda S. Sleep quality and duration – Potentially modifiable risk factors for Coronary Artery Disease? Indian Heart J. 2014 Nov-Dec;66(6):565-8.
  • Sarat Chandra K, Bansal M, Nair T, Iyengar SS, Gupta R, Manchanda SC, Mohanan PP, Dayasagar Rao V, Manjunath CN, Sawhney JP, Sinha N, Pancholia AK, Mishra S, Kasliwal RR, Kumar S, Krishnan U, Kalra S, Misra A, Shrivastava U, Gulati S. Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J. 2014 Dec;66 Suppl 3:S1-S51.
  • Madan K, Babu AS, Contractor A, Sawhney JP, Prabhakaran D, Gupta R. Cardiac rehabilitation in India. Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):543-50.
  • Satyamurthy I, Dalal JJ, Sawhney JP, Mohan JC, Chogle SA, Desai N, Sathe SP, Maisel AS. The Indian Consensus Document on cardiac biomarker. Indian Heart J. 2014 Jan- Feb;66(1):73-82.
  • Bajaj R, Karthikeyan G, Sinha N, Lokhandwala Y, Rao D, Kaushik SK, Jain SL, Narayanan S, Seth A, Satyamurthi I, Sawhney JP, Saran RK, Sharma S, Haridas KK, Gohkroo RK, Omar AK, Dwivedi SK, Modi S, Kapur KK, Dalvi B, Bharani A, Wander GS, Venugopal K, Mahant TS. CSI consensus statement on prosthetic valve follow up. Indian Heart J. 2012 Dec;64 Suppl 2:S3-S11.
  • Sawhney JP. Angiotensine converting enzyme inhibitors In acute myocardial infarction--a review. Indian Heart J. 2011 Jan-Feb;63(1):71-8.
  • Sawhney JP. First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond. Indian Heart J. 2010 Jan-Feb;62(1):49-56.
  • Grover A, Varma JS, Khattri HN, Anand IS, Sawhney JP, Sapru RP, Bidwai PS, Wahi PL. Role of 2-D echocardiography in atrial tumors. A PGI experience. Indian Heart J. 1987 Nov-Dec;39(6):51-6.
  • Gupta R, Sawhney JP, Narain VS. Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice. Am J Cardiovasc Drugs. 2005;5(5):325-9. PubMed PMID: 16156688.
  • Dalal JJ, Kasliwal RR, Dutta AL, Sawhney JP, Iyengar SS, Dani S, Desai N, Sathyamurthy I, Rao D, Menon A, Dasbiswas A, Wander GS, Chadha M, Hiremath MS, Roy DG, Gupta V, Shivakadaksham N. Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: an Indian consensus statement. Indian Heart J. 2012 Sep-Oct;64(5):503-7.
  • Sundeep Mishra , Saumitra Ray, Jamshed J. Dalal, J.P.S. Sawhney, S. Ramakrishnan, Tiny Nair, S.S. Iyengar, V.K. Bahl. Management standards for stable coronary artery disease in India. Indian Heart Journal. 2016 Dec; 68(3):Pages S31–S49.
  • Bansal M, Sarat Chandra K, Nair T, Iyengar SS, Gupta R, Manchanda SC, Mohanan PP, Dayasagar Rao V, Manjunath CN, Sawhney JP, Sinha N, Pancholia AK, Mishra S, Kasliwal RR, Kumar S, Krishnan U, Kalra S, Misra A, Shrivastava U, Gulati S.Consensus statement on the management of dyslipidemia in Indian subjects: Our perspective. Indian Heart J. 2016 Mar-Apr;68(2):238-41.
  • Mishra S, Ray S, Dalal JJ, Sawhney JP, Ramakrishnan S, Nair T, Iyengar SS, Bahl VK. Management Protocols of stable coronary artery disease in India: Executive summary. Indian Heart J. 2016 Nov - Dec;68(6):868-873.
  • Trailokya A, Hiremath JS, Sawhney J, Mishra YK, Kanhere V, Srinivasa R, Tiwaskar M. Acenocoumarol: A Review of Anticoagulant Efficacy and Safety. J Assoc Physicians India. 2016 Feb;64(2):88-93.
  • Kalra S, Sawhney J, Sahay R. The Draupadi of dyslipidemia: Familial hypercholesterolemia. Indian J Endocrinol Metab. 2016 May-Jun;20 (3):285-7.
  • S.S. Iyengar, et al., Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry, Indian Heart J (2016), http://dx.doi.org/10.1016/j.ihj.2016.09.009
  • Chee Tang Chin, Tiong K. Ong , Rungroj Krittayaphong , Stephen W.-L. Lee , Jitendra P.S. Sawhney , Hyo-Soo Kim , Angeles Alonso Garcia , Héctor Bueno , Stuart J. Pocock , Vo T. Nhan, Ana Vega , Nobuya Hayashi , Yong Huo. Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study. International Journal of Cardiology 243 (2017) 15–20.
  • Jamshed Dalal, Abhay Bhave, Abraham Oomman, JPS Sawhney, Anil Saxena, Dhiman Kahali, Balbir Singh, KK Sethi, Jaydip Ray Chaudhuri, Nakul Sinha, Saumitra Ray, Aparna Jaswal, Viveka Kumar, Suvro Banerjee, Upendra Kaul, SPAF Academy India experts. The Indian Consensus Guidance on Stroke Prevention in Atrial Fibrillation: A Practical View on the Use of Non-Vitamin K Antagonist Oral Anticoagulants. Supplement to Journal of The Association of Physicians of India. Published on 1st of Every Month 1st March, 2018.
  • S Sawhney J, Kahali D, Desai B, Kumar SK, Vishvanathan M, Rastogi V. The role of optimal medical therapy in patients with stable coronary artery disease. J Clin Prev Cardiol 2018; 7:60-71.
  • Setia N, Saxena R, Sawhney JPS, Verma IC. Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected. Indian J Pediatr. 2018 May;85(5):339-343.
  • Saumitra Ray, J.P.S. Sawhney, M.K. Das, Jyoti Deb, Peeyush Jain, Sivakadaksham Natarajan, K.K. Sinha. Adaptation of 2016 European Society of Cardiology/European Atherosclerosis Society guideline for lipid management to Indian patients – A consensus document. Indian Heart Journal, 2018-09-01, Volume 70, Issue 5, Pages 736-744.
  • Apaar Dadlani, Kushal Madan, JPS Sawhney. Ambulatory blood pressure monitoring in clinical practice. Indian Heart Journal. 2018.
  • Himanshu Arora, J. P. S. Sawhney, Ashwani Mehta, Arun Mohanty. Anemia profile in patients with congestive heart failure a hospital based observational study. Indian Heart Journal, 2018.
  • Guha S, Harikrishnan S, Ray S, Sethi R, Ramakrishnan S, Banerjee S, Bahl VK, Goswami KC, Banerjee AK, Shanmugasundaram S, Kerkar PG, Seth S, Yadav R, Kapoor A, Mahajan AU, Mohanan PP, Mishra S, Deb PK, Narasimhan C, Pancholia AK, Sinha A, Pradhan A, Alagesan R, Roy A, Vora A, Saxena A, Dasbiswas A, Srinivas BC, Chattopadhyay BP, Singh BP, Balachandar J, Balakrishnan KR, Pinto B, Manjunath CN, Lanjewar CP, Jain D, Sarma D, Paul GJ, Zachariah GA, Chopra HK, Vijayalakshmi IB, Tharakan JA, Dalal JJ, Sawhney JPS, et al. CSI position statement on management of heart failure in India. Indian Heart J. 2018 Jul;70 Suppl 1:S1-S72.
  • Jan S, Lee SW, Sawhney JPS, Ong TK, Chin CT, Kim HS, Krittayaphong R, Nhan VT, Pocock SJ, Vega AM, Hayashi N, Huo Y. Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia. BMC Cardiovasc Disord. 2018 Jul 4;18(1):139.
  • Poh KK, Ambegaonkar B, Baxter CA, Brudi P, Buddhari W, Chiang FT, Horack M, Jang Y, Johnson B, Lautsch D, Sawhney J, Vyas A, Yan BP, Gitt AK. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-pacific region: results from the Dyslipidemia international Study II. Eur J Prev Cardiol. 2018;25(18):1950-1963.
  • Jitendra PS. Sawhney, Veerappa A. Kothiwale, Vikas Bisne, Rajashekhar Durgaprasad, Praveen Jadhav, Manoj Chopda, Velam Vanajakshamma, Ramdhan Meena, Govindan Vijayaraghavan, Kamaldeep Chawla, Jagan Allu, Karen S. Pieper, A. John Camm, Ajay K. Kakkar, for the GARFIELD-AF Investigators. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights into the GARFIELD-AF Registry. Indian Heart Journal. 2018;70(6): 828-835.
  • J. P. Sawhney, Ajit Mullasari, Dhiman Kahali, Vimal Mehta, Tiny Nair, Upendra Kaul, M. S. Hirematth. Short- and Long-Term Follow-up of Antithrombotic Management Patterns in Patients Hospitalized with Acute Coronary Syndrome (ACS): Indian Subgroup of EPICOR-Asia Study. Indian Heart Journal. 2018.
  • Nitika Setia, Sireesha Movva, Prahlad Balakrishnan, Ishpreet K Biji, JPS Sawhney, Raman Puri, Anjali Arora, Ratna D Puri, Renu Saxena, Sanghamitra Mishra, Sanika Apte, Samarth Kulshrestha, VL Ramprasad & I C Verma. Clinical and Genetic Analysis of Familial Hypercholesterolemia in Asian Indians. Indian Heart Journal. 2018
  • J.P.S. Sawhney,V. Mori,M.K. Sharma,K. Madan,I.C. Verma. Coronary risk factors and arcus cornealis in young patients of coronary artery disease with and without familial hypercholesterolemia. Atherosclerosis 2020; e213.
  • A Mohanty, V Arya, JPS Sawhney, A Saraf, M Bhargava, R Jain, R Passey, A Mehta, RR Mantri, A Makhija, B Khandpal, K Madan. Prasugrel resistance and impact of select gene variants in Indian patient with coronary artery disease. Indian Heart Journal,2018; 70 (suppl 2), S28.
  • N Pansari, RR Mantri, JPS Sawhney, A Mohanty. Efficacy of Ibutilide Fumerate in cardioversion of atrial flutter and atrial fibrillation. Indian Heart Journal,2018; 70 (suppl 2), S88.
  • PR Wankhade, A Mohanty, RR Mantri, A Makhija, R Passey, R Jain, BS Vivek, A Mehta, B Khandpal, M Sharma, JPS Sawhney, SS Kar. One year outcomes of percutaneous coronary intervention with the 48-mm Xience Xpedition Everolimus-eluting stent – a single center study. Indian Heart Journal,2018; 70 (suppl 2), S69.
  • A Bhatia, JPS Sawhney. Study of urinary neutrophil gelatinase associated lipocalin( NGAL) levels as early predictive marker for contrast induced nephropathy in diabetic patients undergoing coronary angioplasty. Indian Heart Journal, 2018; 70 (suppl 2), S103.
  • Fox KAA, Accetta G, Darius H, Goto S, Kayani G, Koretsune Y, Oh S, Parkhomenko A, Sawhney JPS, Stepinska J, Kakkar AK on behalf of GARFIELD-AF Investigators. Do baseline characteristics account for geographical variations in event rates in patients with newly diagnosed atrial fibrillation? The GARFIELD-AF registry.European Society of Cardiology (Rome, Italy, 27th August - 31st August 2016) - Eur Heart J 2015;36(suppl 1):544. P4100, 29 August 2016
  • Yong Huo, Stephen W Lee, Jitendra P Sawhney, Hyo-Soo Kim, Rungroj Krittayaphong, Stuart J Pocock, Vo T Nhan, Chee Tang Chin, Xiaoning Han, Ana Vega, Yohji Itoh, and Tiong K Ong. Long-term Antithrombotic Management Patterns After Acute Coronary Syndromes: 2-years Follow-up in the EPICOR Asia Study. Circulation. 2015;132:A15408
  • U. Kaul, N. Sinha, A. Mishra, A. Mullasari, J. P. S Sawhney, R. Dargad, K. Mehta, D. Pahlajani. Characteristics and medical management of Indian stable angina patients: The Stable Angina obseRvational (STAR) Registry. Indian Heart journal 65 (2013) S1.
  • Mahajan Parag Vijay, Sawhney J. P. S, Mohanty Arun, Arya Vandana, Bhargava Manorama, Sarf Amirita. Aspirin and clopidogrel resistance and their genetic association in Indian patients with coronary artery disease. Indian Heart journal 65 (2013) S5.
  • Sujatha Shetty, J. P. S. Sawhney. Real-world efficacy and safety of valsartanhydrochlorothiazide combination in Indian hypertensive patients uncontrolled on individual monotherapy: Valfast study. Indian Heart journal 65 (2013) S68.
  • Monika Sharma, J.P.S. Sawhney, Parag Mahajan. Distressed personality (Type D): Pre chance to increase the risk of coronary events? Indian Heart journal 65 (2013) S85.
  • Mahajan P.V., Arya V., Mohanty A., Saraf A., Bhargava M. and Sawhney J.P.S. Aspirin and clopidogrel resistance in Indian patients with Coronary Artery Disease (CAD) and their genetic association. Indian Heart J. 2012. 64:S27.
  • Monika Sharma, J.P.S.Sawhney, S.C.Manchanda. Prevalence and correlates of psychosocial distress in patients with acute coronary syndrome. Indian Heart J. 2012. 64:S122.
  • Passey R, Mehta A, Parikh R, Aggarwal S, Gupta A, Mohan R, Sachdeva S, Dhawan S, Mantri RR, Sawhney JPS, Chopra VK, Gupta MP, Khanna PK. Asymptomatic coronary artery disease in patients with symptomatic peripheral vascular disease—Detected by dobutamine stress echo and coronary angiography. Journal of the American College of Cardiology 2002;39:26.
  • Mehta A, Passey R, Dhawan S, Sachdev S, Mohan R, Mantri RR, Sawhney JPS, Chopra VK, Bana A, Shivani G, Yadava OP, Khanna PK. Asymptomatic carotid artery disease in patients with significant coronary artery disease under going coronary artery by pass grafting. Journal of the American College of Cardiology 2002;39:26.
  • Mehta A, Mantri RR, Sawhney JPS, Passey R, Dhawan S, Chopra VK, Khanna PK. Diagnostic utility of carotid sinus massage in patients with unexplained syncope. Journal of the American College of Cardiology 2002;39:238.
  • Lahiri S, Dhall A, Mohan R, Sachdeva S, Sharma V, Dhawan S, Shrivastava S, Khanna PK, Sawhney JPS, Mantri RR, Mehta A, Chopra VK, Passey R. Incidence of congenital heart disease by fetal echocardiography in an urban hospital of Delhi. Indian Heart Journal 2002;54:I359.
  • Dhall A, Sharma V, Dhawan S, Yadav S, Yadava OP, Lahiri S, Khanna PK, Sawhney JPS, Mantri RR, Mehta A, Chopra VK, Passey R, Kandpal B, Jain R. Intramyocardial tuberculosis. Indian Heart Journal 2002;54:N388
  • Dhawan S,Sachdeva S, Mohan R, Jaishaker K,Sharma V, Passey R, Mehta,RR,Sawhney JPS,Jain R,Chopra VK, Khanna PK. Role of mitral annular tissue velocity imaging in routine adult Trans thoracic. Echocardiography, Indian Heart Journal 2003;55;435.
  • Madan R, Dhawan S,Sachdeva S, Mohan R, Jaishanker K, Sharma V, Passey R, Mehta A, Mantri RR, Sawhney JPS,Jain R, Chopra VK,KhannaPK,Role of N-accety cysteine in the prevention of contrast induced nephropathy in patients with renal; insufficiency during coronary angiography Indian Heart Journal 2003;55;433
  • Sawhney JPS, Mehta A, Manchanda S,passey R, Mantri RR, Khanna PK,Chopra VK,Sharma V,Dhawan S, Jain R, JaihankerK, Talwar V. Effect of treatment of obstruction sleep apnoea on hypertension. Indian Heart Journal 2003;55:441
  • Talwar V, Sharma V, Dhaman S, Sachdeva S, Mohan R, Jaishanker K,Sharma V,Passey R, Mehta A, Mantri RR, Sawhney JPS, Jain R, Chopra VK, Khanna PK Yadav OP, Gupta MP, Effect of adjunctive intra- coronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with on reflow after primary PTCA in acute MI. Indian Heart Journal 2003;55:443
  • Mehta A, Passey R, Sawhney JPS, Dhawan S, Sachdeva S, Mohan R, Jaishanker K,Shrama V, Passey R, Mehta R, mehta A, Mantri RR, Sawhney JPSJAin R, Chopra Vk,Khanna PK. Medium term comparison of abcixmab and Eqtifibatide in MI following angioplasty . India Heart Journal 2003;55: 543
  • Dhawan S, Mohan R, Sachdeva S, jaishanker K, Sharma V, Passey R, Mehta A, Mantri RR, Sawhney JPS, Jain R, Chopra VK, Khanna PK, Radial Artery Doppler in patient undergoing CABG: Implications as choice of conduit. Indian Heart Journal 2003;55:520
  • Sharma V, Jaishanker K, Dhawan S, Sachdeva S, Mohan R, Sharma V, Passey R, Mehta A, mantri RR, Sawhney JPS, Jain R, Chopra VK, Khanna PK, Gupta Mp, Multicessel intervention during primary angioplasty. Indian Heart Journal 2003; 55:527-8
  • Sharma V, Jaishanker K, Dhawan S, Passey R, Mehta A, Mantri RR, Sawhney JPS Jain R, Chopra VK, Khanna PK, Yadav OP, Gupta MP, short- term clinical results spiral force stents. Indian Heart Journal .2003;55: 530.
  • Passey R, madan R, Mehta A, Sawhney JPS, Dhawan S, Jaishanker K, Sharma V, Mantri RR, Jain R, Chopra VK, Khanna PK, Precautious transluminal coronary angioplasty in patients with chropnic renal failure : In –hospital course . Indian Heart Journal 2003;55:536.
  • Mantri RR, Sawhney JPS, Mehrta A, Sharma R, Sabharwal V, Passey R, Dhawan S, Jaishanker K, Sharma V, Jain R, Chopra VK. Khanna PK. Apical ballooning of the ventricle. Indian Heart Journal 2003;55 545.
  • Mohan R, Sachdeva S, Talwar VK, Mehta A, Passey R, Mantri: RR, Sawhney JPS, Kandpal B, Sharma V, Dhawan S, Jain S, Chopra VK, Khanna PK. Role of head up tilt test in cjlildren vs,'adult. Indian Heart J 2004;56
  • Sharma V, Dhawan S, Mohanty A, Talwar VK, Mantri RR, Mehtra A , Passey R, Jain R, Kandpal B, Sawhney JPS, Chopra.VK, Khanna PK, Manchanda SC. Short ter:m clinical results ,with drug eluting stents Cypher vs. Taxus -SGRH experience. Indian Heart J 2004;56.
  • Sachdeva S, Dhawan S, Mohan R, Mohanty A, Sharma V, Passey R, Mehta A, Mant'ri RR, Kandpal B, Talwar VK, Sawhney JPS, Jain R, 'Chopra VK, Khanna PK, Manchanda.SG;' Distal left ,anterior descending coronary artery imaging by Tran thoracic echocardiography-A preliminary feasibility study 100 consecutive cases. India; Heart) 2004;56.
  • Sharma V, Mohanty A, Dhawan S, Mantri RR, Mehta A, Passey R, Kandpal B, Talwar VK, Sawhney JPS, Jain R, Chopra VK, Khanna PK Manchanda SC:' Multi vessel' intervention. in patient's undergoing primary Angioplasty-Experience at Sir Ganga Ram Hospital. Indian Heart J 2004;56
  • Jain R, Talwar VK: Passey R, Chopra VK, Mantri RR, Sharma V, Mohanty A., Dhawan S, Mehta A, Kandpal B, Sawhney JPS, Khanna PK, Manchanda SC. Drug eluting stents for treating long lesions (> 23 Mm): A single centre experience. Indian Heart J 2004;56
  • Jain R, Mantri RR, Passey R, Chopra VK, Sharma V, Mohanty A, Dhawan S, Talwar VK, Mehta A, Kandpal B, Sawhney JPS, Khanna PK, Manchanda SC. Percutaneous coronary intervention for treating diffuse lesions with overlapping stents: A single centre experience. Indian Heart J 2004;56
  • Talwar VK, Dhawan S, Sharma V, Mohanty A, Mantri RR, Mehta A, Passey R, Kandpal B, Sawhney JPS, Jain R, Chopra VK, Khanna PK, Manchanda Sc. Clinical applicability for the assessment of the valvular mitral stenosis severity with proximal isovelocity surface area (PISA) method correlation with 2 dimensional area and wessure halt time method. Indian Heart J 2004;56
  • Mehta A, Prakash A, Passey R, Mantri RR, Sawhney JPS, Kandpal B, Talwar VK, Sharma V, Dhawan S, Jain R, Chopra VK, Khanna PK .. Nasal continuous positive airway pressure: Effect on cardiac volumes in patients with congestive heart failure. Indian Heart J 2004;56
  • Mehta A, Prakash A, Passey R, Mantri RR, Sawhney JPS, Kandpal B, Sharma V, Talwar VK, Dhawan S, Jain R. Chopra VK, Khanna PK. Cardiac output estimation by transoesophageal doppler monitoring versus thermodilution in the intensive coronary care unit. Indian Heart J 2004;56
  • Dhawan S, Talwar VK, Sachdeva S, Mohan R, Mohanty A, Sharam V, Passey R, mehta A, Mantri RR, Sawhney JPS, Jain R, Chopra VK, Yadava OP, Khanna PK. Radial artery Doppler in 256 consecutive patientsundergoing CABG. Indian Heart J 2004;56
  • Talwar VK, Mohan R, sachdeva S, Mehta A, Passey R, Mantri RR, Sawhney PJS, Kandpal B, Sharma V, Dhawan S, Jain R, Chopra VK, Khanna PK, Head up tilt test in geriatric age group and comparison with adult population. Indian Heart J 2004;56
  • Talwar VK, Mohan R, Sachdeva S, Mehta A, Pasey R, Mantri RR, Sawhney JPS, Kandpal B, Sharma V, Dhawan S, Jain R., Chopra VK, Khanna PK. Head up tilt test – role of isoprenalin . Indian Heart J 2004;56
  • Mohanty A, Manchanda SC, Dhawan S, Sawhney JPS, Mantri RR, Kandpal B, Jain R, Passey R, Mehta A, Mohan R, Sachdeva S, Khanna PK, Jain M, Talwar V. A rare cause of acute coronary syndrome resulting from polycythemia. Indian Heart Journal 2005;57:391
  • Mehta A, Passey R, Sawhney JPS, Mantri RR, Kandpal B, Mohanty A, Dhawan S, Jain R, Mohan R, Sachdeva S, Talwar VK, Khanna PK, Clinical profile of patients of angina withslow flow and normal coronary angiogram. Indian Heart Journal 2005;57:391–2
  • Dhawan, S, Manchanda SC, Mohanty A, Sawhney JPS, Mantri RR, Kandpal B, Jain R.Passey R, Mehta A, Mohan R, Sachdeva S, Khanna PK, Jain M, Talwar V. Comparison of percutaneous radial coronary angiography by single tiger catheter with conventional percutaneous femoral angiography. Indian Heart Journal 2005;57:424
  • Passey R, Talwar VK, Mehta A, Jain R, Khanna PK, Mantri RR, Sawhney JPS, Kandpal B, Mohanty A, Dhawan S, Mohan R, Sachdeva S, Complete myocardial revascularization in the setting of primary percutaneous coronary intervention for acute ST elevation myocardial infarction. Indian Heart Journal 2005;57:429
  • Dhawan S, Mohanty A, Manchanda SC, Mehta A, Passey R, Sawhney JPS, Mantri RR, Kandpal B, Jain R, Mohan R, Sachdeva S, Talwar VK, Jain MK, Khanna PK. Incidence of coronary slow flow in major epicardial vessel other than a culprit vessel during acute myocardial infarction. Indian Heart Journal 2005;57:455
  • Mohanty A, Manchanda SC, Dhawan S, Sawhney JPS, Mantri RR, Kandpal B, Jain R, Passey R, Mehta A, Mohan R, Sachdeva S, Khanna PK, Jain M, Talwar V. Low molecular weight heparin (enoxaparin) could be a lethal choice in mechanical prosthetic heart valve in pregnancy. Indian Heart Journal 2005;57:467
  • Mohanty A, Manchanda SC, Dhawan S, Sawhney JPS, Mantri RR, Kandpal B, Jain R, Passey R, Mehta A, Mohan R, Sachdeva S, Khanna PK, Jain M, Talwar V. An unusual case of complete heart block associated with mitochondrial myopathy. Indian Heart Journal 2005; 57:506.
  • J.P.S. Sawhney . Therapeutic experience of Ticagrelor in Indian patients with acute coronary syndrome: An interim analysis of a non-interventional, prospective, observational study. Indian Heart Journal Volume 69, Supplement 2, November 2017, Page S13.
  • P.R. Wankhade, A. Mehta, R. Joshi, N. Aggarwal, J.P.S. Sawhney. Short term clinical and echocardiographic outcomes after use of polytetrafluoroethylene (PTFE) bicuspid pulmonary valve during the repair of Tetralogy of Fallot. Volume 69, Supplement 2, November 2017
  • Kaushal Gandhi, R.R.Mantri, Rajneesh Jain ,Rajiv Passey, J.P.S.Sawhney, Bhuwanesh Kandpal, Aman Makhija, B.S.Vivek. Identification of conventional and emerging risk factors of atherosclerotic coronary heart disease among women. Volume 69, Supplement 2, November 2017.
  • Arjun Sreekumar, Arun Mohanty, J.P.S. Sawhney, Bhuvanesh Kandpal · Comparison of coronary artery calcium scoring in non-elderly prediabetic patients with normal population. Volume 69, Supplement 2, November 2017
  • S.R. Prasad · J.P.S. Sawhney · I.C. Verma · M. Sharma. The study of prevalence of familial hypercholesterolemia in Indian patients with premature coronary artery disease. Volume 69, Supplement 2, November 2017
  • Study of risk factors and assessment of thromboembolic and bleeding risk in patients with nonvalvular atrial fibrillation (AF). B. Shah · S.C. Manchanda · J.P.S. Sawhney · R.R. Mantri, Volume 69, Supplement 2, November 2017.
  • H. Arora · J.P.S. Sawhney · A. Mehta · R. Jain. A hospital based observational study of iron, B12 and folate deficiency in heart failure patients with or without anemia. Volume 69, Supplement 2, November 2017
  • JPS Sawhney, VA Kothiwale , V Bisne , R Durgaprasad , P Jadhav , M Chopda , S Abraham , RD Meena , G Vijayaraghan , K Chawla . Garfield AF registry – Sub analysis of Indian Data. Volume 69, Supplement 2, November 2017.DOI 10.1016/j.ihj.2017.09.095

Non Indexed Journals

  • Sawhney JPS, Sawhney A. The total risk approach to prevention of coronary heart disease. J.Preventive Cardiology 2011; 1(1): 16-21
  • Madan K, Sawhney JPS. Exercise training in primary prevention of coronary heart disease. . J.Preventive Cardiology 2011; 1(2): 73-78.
  • Madan K, Sawhney JPS. Cardiac Rehabilitation. The Ganga Ram Journal. 2011; 1(6): 343-348.
  • Sawhney JPS. Risk assessment for ischaemic heart disease. The Ganga Ram Journal, 2011; 1(2): 63-70.
  • J P S Sawhney, Simran Sawhney, Saurabh Bagga. Familial hypercholesterolemia–An underdiagnosed and undertreated entity. J Preventive Cardiology 2016; 6(1): 947-953.
  • JPS Sawhney. Dual antiplatelet therapy in case of stable angina undergoing PCI. Encardia 2018; 1(1):1-2.
  • Manish Kumar Sharma, P.K. Chowbey, J.P.S. Sawhney. Effect of bariatric surgery on cardiovascular risk factors. J.Preventive Cardiology 2015; 5(1): 771-779.